What is the ICD-10 code for fetal alcohol syndrome (dysmorphic)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ICD-10 Code for Fetal Alcohol Syndrome (Dysmorphic)

The ICD-10 code for fetal alcohol syndrome with dysmorphic features is Q86.0.

This code specifically captures FAS, which is characterized by the complete constellation of diagnostic features including the characteristic facial dysmorphology.

Understanding the Coding Context

The ICD-10 code Q86.0 is used for fetal alcohol syndrome and represents a significant improvement over the older ICD-9 code 760.71, which was non-specific and included all noxious influences of alcohol affecting the fetus through placenta or breast milk 1. The older code had poor specificity and led to both false positives and underestimation of true FAS prevalence 2.

Diagnostic Requirements for Using Q86.0

To appropriately assign the Q86.0 code, the diagnosis must meet specific clinical criteria. According to the most recent guidelines 3, FAS diagnosis requires all four of the following features:

Required Features:

  • Characteristic facial dysmorphology with ≥2 of these 3 features:

    • Short palpebral fissures (≤10th percentile)
    • Thin vermilion border of upper lip (rank 4 or 5 on lip/philtrum guide)
    • Smooth philtrum (rank 4 or 5 on lip/philtrum guide)
  • Growth deficiency: Height and/or weight ≤10th percentile (prenatal or postnatal)

  • CNS abnormality (structural, neurologic, or functional):

    • Head circumference ≤10th percentile, OR
    • Structural brain anomalies, OR
    • Recurrent nonfebrile seizures, OR
    • Neurobehavioral impairment (cognitive or behavioral deficits ≥1.5 SD below mean)
  • Neurobehavioral impairment as detailed above

Important Clinical Caveats

Prenatal alcohol exposure confirmation is not required for the FAS diagnosis or Q86.0 coding 3, 4. The diagnosis can be made with or without documented maternal alcohol use, as the clinical features themselves are diagnostic when all criteria are met.

Common Pitfalls to Avoid:

  • Don't confuse with other FASD codes: Q86.0 is specifically for full FAS with dysmorphic features. Other conditions on the fetal alcohol spectrum (PFAS, ARND) may require different coding approaches or use of O99.31x codes when maternal alcohol use is the primary focus 5.

  • Age considerations: Facial features may become more difficult to detect after puberty 4, but the code remains valid if the diagnosis was established based on earlier documentation.

  • Avoid using 760.71 (ICD-9): This outdated code lacks specificity and should not be used in ICD-10 systems 1, 2.

Related Codes

For maternal records documenting alcohol use during pregnancy, the O99.31x series may be used, though these have variable positive predictive value (ranging from 10% to 100% depending on the specific code) for actual alcohol exposure 5.

The Q86.0 code should be reserved for the child's medical record when the full diagnostic criteria for FAS are met, particularly emphasizing the presence of the characteristic dysmorphic facial features that distinguish FAS from other alcohol-related conditions.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.